AuroLase

· Nanospectra Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AuroLase, covering 2016-07-18 to 2016-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck [NA]